Home/Filings/4/0001127602-18-036615
4//SEC Filing

MEELIA RICHARD J 4

Accession 0001127602-18-036615

CIK 0000313143other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:04 PM ET

Size

8.6 KB

Accession

0001127602-18-036615

Insider Transaction Report

Form 4
Period: 2018-12-14
Transactions
  • Sale

    Common Stock

    2018-12-14$102.86/sh8,196$843,04128,607 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2018-12-148,1960 total
    Exercise: $36.37From: 2013-07-27Exp: 2019-07-27Common Stock (8,196 underlying)
  • Exercise/Conversion

    Common Stock

    2018-12-14$36.37/sh+8,196$298,08936,803 total
Footnotes (3)
  • [F1]This number includes unvested restricted stock units previously reported.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.56 to $103.26, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001223633

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:04 PM ET
Size
8.6 KB